when given at therapeutic doses ( 5 mg/day ) to human subjects it induced a reduction in the beta-adrenergic receptor number measured by 3h-cgp 12177 specific binding , without any change in the affinity on intact lymphocytes .
C0086418
human
C0001643
beta-adrenergic receptor